Gmd assets are far from great, purely a vehicle and everyone knows. Yes there is a high grade shoot at Ulysses but it won’t sustain 80koz a year for very long. Valuation without RF but with DCN assets is likely $265mil ($140m for R&R, $75mil cash, $50mil infra) - this would be the technical Val. The market factor Val is therefore plus $300mil (ie RF). An independent valuer would have to acknowledge this as per their reporting criteria. A remodel of the Ulysses UG may reveal an over estimation of gold, in my view, which is the reason it never progressed earlier, the sbm board should have had this asset modelled and stress tested given it’s been used as a lever in this deal. Sbm shareholders should be demanding an independent report of the gmd assets value which is likely being strategically avoided. SLR is easier to value because they produce cash and have stated reserves.
- Forums
- ASX - By Stock
- SBM
- Ann: SLR:Improved Proposal to Acquire St Barbara's Leonora Assets
SBM
st barbara limited
Add to My Watchlist
1.69%
!
29.0¢

Ann: SLR:Improved Proposal to Acquire St Barbara's Leonora Assets, page-16
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
29.0¢ |
Change
-0.005(1.69%) |
Mkt cap ! $314.0M |
Open | High | Low | Value | Volume |
30.0¢ | 30.0¢ | 28.5¢ | $1.949M | 6.718M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
26 | 1603620 | 28.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
29.0¢ | 138499 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
23 | 1503982 | 0.285 |
18 | 1789045 | 0.280 |
6 | 817000 | 0.275 |
12 | 318520 | 0.270 |
2 | 120000 | 0.265 |
Price($) | Vol. | No. |
---|---|---|
0.290 | 138499 | 4 |
0.295 | 519535 | 9 |
0.300 | 503757 | 12 |
0.305 | 440824 | 11 |
0.310 | 873042 | 8 |
Last trade - 16.10pm 26/06/2025 (20 minute delay) ? |
Featured News
SBM (ASX) Chart |
The Watchlist
PTX
PRESCIENT THERAPEUTICS LIMITED
James McDonnell, CEO
James McDonnell
CEO
Previous Video
Next Video
SPONSORED BY The Market Online